Heineken NV (HEIA:NA) (OTC: OTC:HEINY), currently valued at $44.92 billion, received a stock rating upgrade from RBC Capital, moving from 'Underperform' to 'Sector Perform'. The firm also increased ...

Biogen stock took a hit Wednesday after the biotech company issued light guidance for 2025 despite beating most fourth-quarter expectations.

RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

State of Alaska Department of Revenue cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the ...

MICHAEL HARTNETT, President and CEO at RBC Bearings RBC -0.63% Get Free Report , executed a substantial insider sell on February 10, according to an SEC filing.

We recently published a list of 10 AI News Updates You Should Not Miss. In this article, we are going to take a look at where Amazon.com, Inc.

Analysts suggest hedge fund will want board room shake-up, E&P focus, asset sales, spin-offs and could 'smoke out' corporate ...

Shares of RBC Bearings Incorporated (NYSE:RBC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are currently covering the firm, Marketbeat reports.

Since Palantir reported results, Yahoo Finance data shows there have been several upward revisions to EPS expectations for ...